Campylobacter jejuni as a cause of traveler's diarrhea: Clinical features and antimicrobial susceptibility

Journal of Travel Medicine

Volumn 5, Issue 1, 1998, Pages 23-26

  Gallardo, Francisco ^a   Gascón, Joaquim ^a   Ruiz, Joaquim ^a   Corachan, Manuel ^a   Jimenez De Anta, Ma Teresa ^a   Vila, Jordi ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; NALIDIXIC ACID; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; CAMPYLOBACTER JEJUNI; CLINICAL ARTICLE; CLINICAL FEATURE; HUMAN; TRAVELLER DIARRHEA; DIARRHEA; DRUG EFFECT; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PREVALENCE; SPAIN; TRAVEL;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; DIARRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; SPAIN; TRAVEL;

EID: 0031593449     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.1998.tb00451.x     Document Type: Article

References (29)

1. Black RE. Epidemiology of traveler's diarrhea and relative importance of various pathogens. Rev Infect Dis 1990; 12(Suppl 1):S73-S79.
2. Taylor DN, Blaser MJ, Blacklow N, et al. Polymicrobial aetiology of travellers diarrhoea. Lancet 1985; 1:381-383.
3. Gascón J, Vila J, Valls ME, et al. Etiology of traveller's diarrhea in Spanish travellers to developing countries. Eur J Epidemiol 1993; 9:217-223.
4. Blaser MJ, Reller LB. Campylobacter enteritis. N Engl J Med 1981; 10:1444-1451.
5. Pichler HET, Diridl G, Stickler K, Wolf D. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. Am J Med 1987;82(Suppl 4A):329-332.
6. Goodman LJ, Trenholme GM, Kaplan LR, et al. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med 1990; 150:541-546.
7. Petruccelli DP, Murphy GS, Sanchez JL, et al. Treatment of traveler's diarrhea with ciprofloxacin and loperamide. J Infect Dis 1992; 165:557-560.
8. National Committee for Clinical Laboratory Standard: Performance standards for antimicrobial disk susceptibility tests. M2-A4, 4th Ed. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1990.
9. Karmali MA, Penner JL, Fleming PC, et al. The serotype and biotype distribution of clinical isolates of Campylobacter jejuni and Campylobacter coli over a three year period. J Infect Dis 1983; 147:243-246.
10. Georges-Courbot MC, Baya C, Beraud AM, et al. Distribution and serotypes of Campylobacter jejuni and Campylobacter coli in enteric Campylobacter strains isolated from children in the Central African Republic. J Clin Microbiol 1986; 23: 592-594.
11. Black RE. Pathogens that cause traveler's diarrhea in Latin America and Africa. Rev Infect Dis 1986; 8(Suppl 2): S131-135.
12. Ryder RW, Oquist CA, Greenberg H, et al.Travelers' diarrhea in Panamanian tourist in Mexico. J Infect Dis 1981; 1441: 442-448.
13. Pitkanen T. Travellers' diarrhoea caused by Campylobacter jejuni. Ann Clin Res 1982; 14:111-113.
14. Mattila L, Siitonen A, Kyronseppa H, et al. Seasonal variation in etiology of travelers' diarrhea. J Infect Dis 1992; 165: 385-388.
15. Speelman P, Struelens MJ, Sanyal SC, Glass RI. Detection of Campylobacter jejuiii and other potential pathogens in travellers' diarrhoea in Bangladesh. Scand J Gastroenterol 1983; 84: 19-23.
16. Echeverria P, Jackson LR, Hoge CW, et al. Diarrhea in U.S. troops deployed to Thailand. J Clin Microbiol 1993; 31: 3351-3352.
17. Skirrow MB. Campylobacter. Lancet 1990; 336:921-923.
18. Blaser MJ, Berkowitz ID, LaForce FM, et al. Campylobacter enteritis: clinical and epidemiological features. Ann Intern Med 1979; 91:179.
19. Skirrow MB. Campylobacter enteritis: a "new" disease. BMJ 1977; 2:9-11.
20. Karmali MA, Fleming PC. Campylobacter enteritis in children. J Pediatr 1979; 94:527-533.
21. Blaser MJ. Campylobacter and related species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingston, 1995: 1948-1956.
22. Vanhoff R, Vanderlinden MP, Dierickx R, et al. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother 1978; 14: 553-556.
23. Walder M, Forgren A. Erythromycin-resistant campylobacters. Lancet 1978; (ii):1201.
24. Goosens H, De Mol P, Coignan H, et al. Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU 28965 (a new macrolide) and other agents against enteropathogens. Antimicrob Agents Chemother 1985; 27:388-392.
25. Segreti J, Nelson JA, Goodman LJ, et al. In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea. Antimicrob Agents Chemother 1989; 33:1385-1387.
26. Endtz HPh, Ruijs GJ, Van Klingeren B, et al. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother 1991; 27:199-208.
27. Johnson PC, Ericsson CD, Morgan DR, et al. Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin. Antimicrob Agents Chemother 1986; 30:671-674.
28. Rademaker CM, Hoepelman IM, Wolfhagen MJ, et al. Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers diarrhea. Eur J Clin Microbiol Infect Dis 1989; 8:690-694.
29. Wistrom J, Norrby SR, Burman LG, et al. Norfloxacin versus placebo for prophylaxis against traveller's diarrhoea. J Antimicrob Chemother 1987; 20:563-574.